Literature DB >> 1478370

Hyperproinsulinaemia in patients with myotonic dystrophy.

A J Krentz1, P M Clark, L Cox, A C Williams, M Nattrass.   

Abstract

Hyperinsulinaemia is a reported feature of the inherited multisystem disorder myotonic dystrophy. This phenomenon has been attributed to a compensatory beta cell response to tissue insulin resistance. In this study, circulating concentrations of insulin, proinsulin, and split proinsulin molecules were determined after an overnight fast in ten patients with myotonic dystrophy using two-site monoclonal antibody-based immunoradiometric assays. Results were compared with ten healthy control subjects matched for age, gender, and body mass index. Oral glucose tolerance (75 g), as defined by World Health Organization criteria, was normal in all subjects. Fasting plasma immunoreactive insulin concentration, as determined using a conventional radioimmunoassay, was almost three times higher (p < 0.005) in the myotonic dystrophy patients than the healthy control subjects. By contrast, fasting concentrations (mean +/- SEM) of C-peptide (0.75 +/- 0.09 vs 0.52 +/- 0.03 nmol/l, p = 0.07) and immunoradiometrically-determined insulin (60 +/- 12 vs 38 +/- 4 pmol/l, p = 0.09) were not significantly different between the groups. Fasting concentrations of proinsulin (10.3 +/- 2.9 vs 1.6 +/- 0.3 pmol/l, p < 0.01), and 32-33 split proinsulin (7.8 +/- 2.5 vs 2.9 +/- 0.4 pmol/l, p < 0.05) were significantly elevated in the patients with myotonic dystrophy. Accordingly, the mean fasting proinsulin:insulin ratio, expressed as a percentage, was significantly increased in the myotonic patients (20 +/- 5 vs 4 +/- 1%, p < 0.01). The overall C-peptide response to the oral glucose challenge was significantly greater in the myotonic patients compared with the healthy control subjects (p < 0.001). These results provide corroborative evidence of increased beta-cell secretion in myotonic dystrophy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1478370     DOI: 10.1007/bf00401372

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

1.  Raised proinsulin concentration as early indicator of beta cell dysfunction.

Authors:  D R Williams; C Byrne; P M Clark; L Cox; N E Day; G Rayman; T Wang; C N Hales
Journal:  BMJ       Date:  1991-07-13

Review 2.  Diabetes mellitus. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1985

3.  Abnormal regulation of intermediary metabolism after oral glucose ingestion in myotonic dystrophy.

Authors:  A J Krentz; N H Coles; A C Williams; M Nattrass
Journal:  Metabolism       Date:  1990-09       Impact factor: 8.694

4.  Insulin deficiency in non-insulin-dependent diabetes.

Authors:  R C Temple; C A Carrington; S D Luzio; D R Owens; A E Schneider; W J Sobey; C N Hales
Journal:  Lancet       Date:  1989-02-11       Impact factor: 79.321

5.  Receptor binding and biological potency of several split forms (conversion intermediates) of human proinsulin. Studies in cultured IM-9 lymphocytes and in vivo and in vitro in rats.

Authors:  D E Peavy; M R Brunner; W C Duckworth; C S Hooker; B H Frank
Journal:  J Biol Chem       Date:  1985-11-15       Impact factor: 5.157

6.  Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins.

Authors:  W J Sobey; S F Beer; C A Carrington; P M Clark; B H Frank; I P Gray; S D Luzio; D R Owens; A E Schneider; K Siddle
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

7.  The direct relationship of proinsulin-insulin hypersecretion to basal serum levels of cholesterol and triglyceride in myotonic dystrophy.

Authors:  P L Poffenbarger; T Bozefsky; J S Soeldner
Journal:  J Lab Clin Med       Date:  1976-03

8.  Insulin resistance in multiple aspects of intermediary metabolism in myotonic dystrophy.

Authors:  A J Krentz; A C Williams; M Nattrass
Journal:  Metabolism       Date:  1991-08       Impact factor: 8.694

Review 9.  Insulin receptors and insulin resistance.

Authors:  J S Flier
Journal:  Annu Rev Med       Date:  1983       Impact factor: 13.739

10.  Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes.

Authors:  R H Unger; S Grundy
Journal:  Diabetologia       Date:  1985-03       Impact factor: 10.122

  10 in total
  4 in total

1.  Regulation of Insulin Receptor Trafficking by Bardet Biedl Syndrome Proteins.

Authors:  Rachel D Starks; Andreas M Beyer; Deng Fu Guo; Lauren Boland; Qihong Zhang; Val C Sheffield; Kamal Rahmouni
Journal:  PLoS Genet       Date:  2015-06-23       Impact factor: 5.917

Review 2.  Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1.

Authors:  Sylvia Nieuwenhuis; Kees Okkersen; Joanna Widomska; Paul Blom; Peter A C 't Hoen; Baziel van Engelen; Jeffrey C Glennon
Journal:  Front Neurol       Date:  2019-11-26       Impact factor: 4.003

Review 3.  Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention.

Authors:  Inês Caldeira Brás; Annekatrin König; Tiago Fleming Outeiro
Journal:  J Huntingtons Dis       Date:  2019

4.  Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action.

Authors:  Esther Llagostera; Daniele Catalucci; Luc Marti; Marc Liesa; Marta Camps; Theodore P Ciaraldi; Richard Kondo; Sita Reddy; Wolfgang H Dillmann; Manuel Palacin; Antonio Zorzano; Pilar Ruiz-Lozano; Ramon Gomis; Perla Kaliman
Journal:  PLoS One       Date:  2007-11-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.